Elizabeth Stover, MD, PhD
Elizabeth Stover, MD, PhD is a medical oncologist in the Division of Gynecologic Oncology at Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard Medical School. She received her BA in Biology from Harvard College, M.Phil. in Medical Sciences from Cambridge University (United Kingdom), and MD and PhD from Harvard Medical School, with PhD research in the biology of hematologic malignancies with D. Gary Gilliland MD, PhD. She completed internal medicine residency at Brigham and Women’s Hospital, and hematology and oncology fellowship training at Dana-Farber Cancer Institute and Massachusetts General Hospital. Her postdoctoral fellowship training has been conducted under the mentorship of Levi A. Garraway MD, PhD, Matthew Meyerson MD, PhD, and Cory Johannessen, PhD at Dana-Farber Cancer Institute and the Broad Institute.
Her research focuses on genomic and functional approaches to understanding drug response and resistance in ovarian cancer and other gynecologic malignancies. Current research efforts aim to understand mechanisms of apoptotic cell death induced by chemotherapy and targeted agents in ovarian cancer and how to modulate apoptotic pathways to improve disease responses. She is a recipient of an American Society for Clinical Oncology Young Investigator Award and a Rivkin Center for Ovarian Cancer Scientific Scholar Award.